$327 million—that was the verdict handed down in 2011 against Johnson & Johnson’s subsidiary, Janssen Pharmeceuticals, for illegally marketing Rispderal. …

$327 million—that was the verdict handed down in 2011 against Johnson & Johnson’s subsidiary, Janssen Pharmeceuticals, for illegally marketing Rispderal. …
An ongoing Risperdal settlement is underway against drug manufacturer Janssen Pharmaceuticals and their parent company, Johnson & Johnson. Risperdal attorneys …
Risperdal is one of the greatest medical ironies. That’s because young boys taking it for severe psychosis may develop Risperdal …
Powerful drugs come with powerful side effects. Risperdal effectively treats several mental illnesses, but can also cause significant damage. One …
Johnson & Johnson recently agreed to pay almost $8 million in a Risperdal settlement.
Manufactured by Janssen, a subsidiary of Johnson & Johnson, Risperdal is an antipsychotic drug originally formulated to treat schizophrenia.
Many drugs are thoroughly tested by both pharmaceutical companies, helping ensure their safety during patient use.
Many drugs and medical devices are currently taking heat for unexpected side effects and complications, but one manufacturer is at the forefront of the conversation: Johnson & Johnson.
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
Johnson and Johnson has to pay $2.5 million in damages to the family of a boy who developed size 46 DD breasts from taking the drug Risperdal.